Come up with a name for your new list and we'll add to it:
BioreclamationIVT raised a round of funding on January 19, 2016. Investors include
Arsenal Capital Partners.
BioreclamationIVT is a provider of biological and in vitro products to the biopharmaceutical, diagnostic, and biotechnology organizations. BioIVT's products are used in drug discovery, biomarker, toxi…